Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.60
Bid: 17.42
Ask: 18.48
Change: 0.79 (4.60%)
Spread: 1.06 (6.085%)
Open: 17.48
High: 17.60
Low: 17.12
Prev. Close: 17.16
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

7 May 2015 07:00

RNS Number : 4268M
Nanoco Group PLC
07 May 2015
 

 

For immediate release

7 May 2015

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Appointment of Chief Financial Officer

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, is pleased to announce the appointment of David Blain as Chief Financial Officer.

 

David, who will join Nanoco and the Company's Board on 3 August 2015, is a chartered accountant with considerable operational, commercial and strategic experience gained at a number of businesses quoted on the London Stock Exchange. He is joining Nanoco from the role of Chief Financial Officer at Inspired Capital plc, an AIM traded finance provider.

 

After qualifying as a chartered accountant David joined the Newcastle office of Price Waterhouse (now PwC), where he worked for nine years in audit and business advisory services. He then spent 11 years as the Finance Director of Drew Scientific Group plc, a medical diagnostics company on the main market. His next role was at the AIM traded IT business, eg Solutions plc, after which he became Chief Financial Officer of Renovo Group plc, the Manchester-based biotechnology company that later became Inspired Capital plc.

 

Michael Edelman, Nanoco's Chief Executive Officer, commented: "We are delighted that David Blain is joining the Nanoco management team as Chief Financial Officer at this exciting stage in the Company's development. David has a wealth of financial and commercial experience and we look forward to his contribution to the future growth of Nanoco.

 

"I would also like to thank Mark Sullivan, who has provided outsourced accountancy services to Nanoco for many years, for his role since October last year as Interim Chief Financial Officer."

 

 

There are no further disclosures required under paragraph 9.6.13 of the UKLA's Listing Rules.

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Mark Sullivan, Interim Chief Financial Officer

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Simon Atkinson

Richard Bootle

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALIFFEEEIDIIE
Date   Source Headline
22nd Dec 20163:55 pmRNSDirector/PDMR Shareholding
22nd Dec 20167:00 amRNSNotification of Major Interest in Shares
20th Dec 20164:13 pmRNSNotification of Major Interest in Shares
19th Dec 20165:38 pmRNSNotification of Major Interest in Shares
15th Dec 20164:15 pmRNSResult of AGM
15th Dec 20167:00 amRNSAGM Statement
12th Dec 20167:00 amRNSNotification of Major Interest in Shares
9th Dec 20163:00 pmRNSNotification of Major Interest in Shares
6th Dec 20168:55 amRNSNotification of Major Interest in Shares
2nd Dec 20162:25 pmRNSNotification of Major Interest In Shares
28th Nov 20167:00 amRNSAcquires Quantum Dot Patents from Kodak
23rd Nov 20167:00 amRNSNotification of Transactions by Directors/PDMRs
17th Nov 20163:22 pmRNSNotification of Major Interest in Shares
7th Nov 20166:26 pmRNSTR-1 NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Nov 20167:00 amRNSAnnual Report & Accounts 2016
17th Oct 20163:15 pmRNSDirector Share Purchase
17th Oct 20161:00 pmRNSNotification of Major Interest in Shares
14th Oct 201612:45 pmRNSDirector Share Purchase
13th Oct 20162:55 pmRNSDirector Share Purchase
13th Oct 20162:43 pmRNSNotification of Major Interest in Shares
11th Oct 20167:00 amRNSPreliminary Results
7th Oct 20167:00 amRNSUpdate re Unaudited Revenues
4th Oct 20167:00 amRNSWebcast of Preliminary Results
20th Sep 20167:00 amRNSNotification of Preliminary Results
8th Sep 20161:05 pmRNSNotification of major interest in shares
31st Aug 201611:29 amRNSNotification of Major Interest in Shares
31st Aug 20167:00 amRNSTotal Voting Rights
30th Aug 20163:05 pmRNSBlock Listing Six Monthly Return
18th Aug 20165:55 pmRNSNotification of Major Interest in Shares
17th Aug 201612:35 pmRNSNotification of Major Interest in Shares
17th Aug 20167:00 amRNSChange of Adviser
10th Aug 201612:50 pmRNSNotification of Major Interest in Shares
8th Aug 20167:00 amRNSNanoco to present at Canaccord Conference
8th Aug 20167:00 amRNSFull Year Trading Update
1st Aug 20167:00 amRNSNanoco and Merck Sign Agreement
28th Jul 20163:55 pmRNSNotification of Major Interest in Shares
26th Jul 20165:31 pmRNSAppointment of Senior Independent Director
22nd Jul 201611:00 amRNSCommercialisation Agreement in Display
20th Jul 20163:45 pmRNSNotification of Major Interest in Shares
13th Jul 201612:06 pmRNSNotification of Major Interest in Shares
12th Jul 201610:30 amRNSNotification of Major Interest in Shares
4th Jul 20163:30 pmRNSNotification of Major Interest in Shares
1st Jul 20163:51 pmRNSShare Price Movement
14th Jun 20165:20 pmRNSNotification of Major Interest in Shares
14th Jun 20167:00 amRNSNotes Publication of Oeko-Institut Report
8th Jun 201611:45 amRNSNotification of Major Interest in Shares
2nd Jun 20169:35 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
27th May 20163:15 pmRNSNotification of Major Interest in Shares
23rd May 20165:15 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
20th May 20167:00 amRNSTo Present at SID Display Week Conference 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.